in cerebrovascular disease there is reasonable evidence that the administration of sulfinpyrazone can significantly reduce cerebral ischemia or mortality , but similar trials performed with aspirin , dipyridamole or clofibrate failed to reveal a significant difference in favor of the experimental treatment .
C0007785
cerebral
C0004057
aspirin